Global Drug Delivery Devices Market, By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The drug delivery devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 16.73% in the forecast period of 2021 to 2028. The growing number of clinical trials for Covid-19 vaccine will help in escalating the growth of the drug delivery devices market. The drug delivery devices market includes of the sales of medical devices and tools that are utilized for delivering definitive kind of drugs to a specific part of the body to cure chronic diseases such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases.
The market comprises the sales of the devices that are categorically made for delivering the certain drugs according to the several controlling techniques for example oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery and implantable drug delivery. Increase in this market is mostly boosted by the factors for instance increasing incidences of chronic diseases, increase in the biologics market, and hi-tech developments and new product launches. There are high numbers of drugs and vaccines in several clinical trial stages which are anticipated to be inaugurated in coming months or years under emergency management authorization guidelines for treating COVID-19. Drug delivery devices, specifically respiratory-based delivery devices, are expected to gain demand because of the COVID-19 pandemic. Drugs used for COVID-19 treatment are both oral and injectable, but a minimal rise is estimated for pulmonary or respiratory-based drug delivery devices.
This drug delivery devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on drug delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Drug Delivery Devices Market Scope and Market Size
The drug delivery devices market is segmented on the basis of route of administration, patient care setting and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on route of administration, the drug delivery devices market is segmented into oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, implantable drug delivery.
- Based on patient care setting, the drug delivery devices market is segmented into hospitals, diagnostic centers, ambulatory surgery centers or clinics, home care settings, others.
- Based on application, the drug delivery devices market is segmented into cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, others.
Drug Delivery Devices Market Country Level Analysis
The drug delivery devices market is analysed and market size insights and trends are provided by country, route of administration, patient care setting and application as referenced above.
The countries covered in the drug delivery devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the drug delivery devices market because of the factors such as increase in biologics in the drug delivery market; the rising incidences of chronic diseases for example cancer, respiratory allergies, and diabetes; growing of the patient compliance to inventing drug delivery advancements; and the existence of a huge number of noticeable players in this region. Asia-Pacific is expected to show large amount of growth in the forecast period because of the increasing incidences of chronic diseases for example cardiovascular diseases, diabetes, cancer and other diseases which is anticipated to drive the drug delivery devices market.
The country section of the drug delivery devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Drug Delivery Devices Market Share Analysis
The drug delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug delivery devices market.
The major players covered in the drug delivery devices market report are BD.; F. Hoffmann-La Roche Ltd; Antares Pharma; Novartis AG; 3M; Sulzer Ltd; Gerresheimer AG; Sanofi; Johnson & Johnson Services, Inc.; Bayer AG; GlaxoSmithKline plc; Novosanis; MEDMIX SYSTEMS AG; Merck & Co., Inc.; Pfizer Inc.; Insulet Corporation; OraSure Technologies, Inc.; Enable Injections; West Pharmaceutical Services, Inc.; SMC Ltd.; ViVO Smart Medical Devices Ltd. and Cipla Inc. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Drug Delivery Devices Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.